ask="5.05"
ask_size="1000"
average_daily_volume="1589390"
bid="4.00"
bid_size="200"
book_value="0.21"
change="-0.21"
change_from_200_day_moving_average="-0.56"
change_from_50_day_moving_average="-0.91"
change_from_52_week_high="-3.02"
change_From_52_week_low="1.67"
change_in_percent="-4.21%"
close="4.78"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.56"
ebitda="-113.37M"
eps_estimate_current_year="-1.45"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.61"
ex_dividend_date="N/A"
float_shares="71244000"
high="5.20"
high_52_weeks="7.80"
last_trade_date="2/1/2017"
last_trade_price="4.78"
last_trade_size="44195"
last_trade_time="4:00pm"
low="4.70"
low_52_weeks="3.11"
market_capitalization="506.49M"
moving_average_200_day="5.34"
moving_average_50_day="5.69"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.21"
open="5.01"
pe_ratio="N/A"
peg_ratio="-0.03"
percent_change_from_200_day_moving_average="-10.49%"
percent_change_from_50_day_moving_average="-16.00%"
percent_change_from_52_week_high="-38.72%"
percent_change_from_52_week_low="+53.70%"
previous_close="4.99"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="23.99"
price_per_sales="18.73"
revenue="28.23M"
shares_outstanding="105960000"
short_ratio="15.67"
stock_exchange="NCM"
symbol="KERX"
volume="1312747"
weeks_range_52="3.11 - 7.80"
